Target intelligence / Profile preview

Long intergenic non-protein coding RNA 334 (LINC00334)

Target
LINC00334
Molecular classification
Long non-coding RNA, Long intergenic non-coding RNA (lincRNA)
01

Overview

Long intergenic non-protein coding RNA 334 (LINC00334, also known as C21orf89 or NCRNA00334) is a member of the long non-coding RNA (lncRNA) family, specifically the long intergenic non-coding RNAs (lincRNAs)[1][5]. LincRNAs are defined as autonomously transcribed non-coding RNAs longer than 200 nucleotides, arising from regions in the genome that do not overlap with annotated protein-coding genes[1][5]. These RNAs can regulate gene expression at the transcriptional and epigenetic level, often displaying tissue-specific functions. LincRNAs may participate in chromatin remodeling, RNA stability regulation, or act as scaffolds or decoys in gene regulatory networks, though the specific biological roles of many individual lincRNAs, including LINC00334, remain incompletely characterized[1][5]. There is currently no evidence that LINC00334 functions as a protein, enzyme, receptor, transporter, or other classical drug target. Likewise, there are no reported roles in human disease, drug interactions, or use as a biomarker in the scientific literature. This reflects the general status of many lincRNAs, where functions are putative rather than experimentally validated for individual members like LINC00334[1][5].

Other names
C21orf89NCRNA00334LINC00334
02

Biological functions

Putative regulation of gene expressionChromatin remodelingRNA stabilizationTranscriptional regulation, including enhancer-associated activity

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 334 (LINC00334).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 334 (LINC00334).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call